|
|
Volumn 50, Issue 14, 2014, Pages 2375-2389
|
|
Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001)
|
|
Author keywords
Breast; Chemotherapy; Early; Patient reported outcomes; Quality of life; Randomised controlled trial
|
|
Indexed keywords
ANTHRACYCLINE;
ANTINEOPLASTIC AGENT;
BRIDGED COMPOUND;
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
FLUOROURACIL;
METHOTREXATE;
TAMOXIFEN;
TAXANE;
TAXOID;
ADJUVANT CHEMOTHERAPY;
ADULT;
BREAST NEOPLASMS;
CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
MIDDLE AGED;
MULTICENTER STUDY;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
THERAPY;
UNITED KINGDOM;
ADULT;
ANTHRACYCLINES;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
BRIDGED COMPOUNDS;
CHEMOTHERAPY, ADJUVANT;
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
FEMALE;
FLUOROURACIL;
GREAT BRITAIN;
HUMANS;
METHOTREXATE;
MIDDLE AGED;
QUALITY OF LIFE;
QUESTIONNAIRES;
TAMOXIFEN;
TAXOIDS;
THERAPEUTICS;
|
|
EID: 85027935627
PISSN: None
EISSN: 18790852
Source Type: Journal
DOI: 10.1016/j.ejca.2014.06.007 Document Type: Article |
|
Times cited : (36)
|
|
References (0)
|
